Drug Shortage Report for TEVA-SUCRALFATE

Last updated on 2021-04-08 History
Report ID 136759
Drug Identification Number 02045702
Brand name TEVA-SUCRALFATE
Common or Proper name SUCRALFATE 1GM TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SUCRALFATE
Strength(s) 1G
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code A02BX
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-30
Estimated end date 2021-04-30
Actual end date 2021-04-07
Shortage status Resolved
Updated date 2021-04-08
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-04-08 French Compare
v3 2021-04-08 English Compare
v2 2021-04-01 French Compare
v1 2021-04-01 English Compare